Drugs In R&d

Journal Title：Drugs In R&d

Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy.

The Journal includes:

Clinical research on new and established drugs;

Preclinical research of direct relevance to clinical drug development;

Short communications and case study reports that meet the above criteria will also be considered;

Reviews may also be considered.

《药物研发》是一本国际性、同行评审、开放获取、仅在线的期刊，提供药物研发各个阶段的及时信息，为临床实践提供参考。因此，医疗保健决策者可以了解药物在治疗中的发展情况。

该期刊包括：

新药和成熟药物的临床研究；

与临床药物开发直接相关的临床前研究；

符合上述标准的简短通讯和案例研究报告也将被考虑；

评论也可能被考虑。

Drugs In R&d创刊于1999年，由Springer International Publishing出版商出版，收稿方向涵盖Pharmacology, Toxicology and Pharmaceutics - Pharmacology全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度8 Weeks，影响因子指数2.5，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。